Molecular Formula | C26H23F4N9O |
Molar Mass | 553.51 |
Density | 1.57±0.1 g/cm3(Predicted) |
Solubility | DMSO: ≥ 30 mg/mL |
pKa | 11.66±0.50(Predicted) |
Storage Condition | -20℃ |
In vitro study | INCB039110 is a potent, selective JAK1 inhibitor, with 20 and 200-fold greater selectivity for JAK1 than for JAK2 and JAK3, respectively. The activities against JAK1, 2, 3 and TYK2 were 2, 63, >2000 and 795 nM, respectively. |
In vivo study | The use of clinical doses of INCB039110, either alone or in combination with a toxic agent such as gemcitabine, prevents tumor growth in mice bearing pancreatic xenograft tumors. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.807 ml | 9.033 ml | 18.066 ml |
5 mM | 0.361 ml | 1.807 ml | 3.613 ml |
10 mM | 0.181 ml | 0.903 ml | 1.807 ml |
5 mM | 0.036 ml | 0.181 ml | 0.361 ml |